Eden Research (EDEN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.000p
   
  • Closing Price Chg:
      0.000p
  • 52 Week High: 4.00p
  • 52 Week Low: 2.00p
  • Currency: UK Pounds
  • Shares Issued: 533.35m
  • Volume: 0
  • Beta: 0.01

Eden Research fungicide added to German organics list

By Josh White

Date: Wednesday 11 Dec 2024

LONDON (ShareCast) - (Sharecast News) - Sustainable biopesticides and biocontrol specialist Eden Research announced on Wednesday that its flagship fungicide Mevalone has been added to the Organic Input List by FiBL Germany - a key certification for products used in organic farming.
The AIM-traded firm said the inclusion followed the approval of Mevalone in Germany earlier in the year.

It said the Organic Input List is managed by the Research Institute of Organic Agriculture (FiBL), an organisation focussed on sustainability and organic farming standards.

The certification confirmed that Mevalone met stringent requirements for use in organic production across Germany and several other countries.

Eden said the registration aligned with Germany's 2030 organic strategy, which aimed to increase organic farmland to 30% by the end of the decade - exceeding the EU Green Deal target of 25%.

Mevalone could play a pivotal role in helping German farmers meet those goals while maintaining productivity, the company explained, by providing effective control of fungal diseases in compliance with organic standards.

"Mevalone's inclusion in the Organic Input List by FiBL Germany provides us with another vital organic registration in an important market, following in the footsteps of Greece, Italy, and France," said chief executive officer Sean Smith.

"Our products' organic compliance demonstrates their sustainable qualities based on Eden's terpene chemistry, as well as their strong efficacy, even when compared with conventional pesticides."

Smith said Germany currently had about 10% of its apple orchards and 15% of vineyard areas dedicated to organic farming, adding that indications were that the proportions of organic farmland were growing rapidly.

"Against this backdrop, we have strategically positioned Mevalone as one of the leading alternative fungicide products that fits both the conventional and organic farming needs."

At 1100 GMT, shares in Eden Research were up 3.9% at 4p.

Reporting by Josh White for Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Eden Research Market Data

Currency UK Pounds
Share Price 3.00p
Closing Price Change 0.000p
% Change 0.00 %
52 Week High 4.00p
52 Week Low 2.00p
Volume 0
Shares Issued 533.35m
Beta 0.01

Eden Research Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
10.18% below the market average10.18% below the market average10.18% below the market average10.18% below the market average10.18% below the market average
17.07% below the sector average17.07% below the sector average17.07% below the sector average17.07% below the sector average17.07% below the sector average
Price Trend
56.69% below the market average56.69% below the market average56.69% below the market average56.69% below the market average56.69% below the market average
22.73% below the sector average22.73% below the sector average22.73% below the sector average22.73% below the sector average22.73% below the sector average
Income Not Available
Growth
55.15% above the market average55.15% above the market average55.15% above the market average55.15% above the market average55.15% above the market average
58.62% above the sector average58.62% above the sector average58.62% above the sector average58.62% above the sector average58.62% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Eden Research Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

Eden Research Key Personnel

CFO Alexander John Abrey
CEO Sean M. Smith

Top of Page